Abstract
High levels of arginase have been detected in gastric adenocarcinoma. To examine the hypothesis that this is due to macrophage infiltration into the tumour, we localized the cellular distribution of arginase by immunohistochemical staining. We examined gastric adenocarcinomas and their corresponding normal tissues (n=45), leiomyomas (n=2), leiomyosarcomas (n=3), human gastric adenocarcinoma cell lines (n=3), and benign gastric ulcers (n=4) by the avidin-biotin-peroxidase complex technique. Macrophages with strong arginase immunoreactivity were observed infiltrating both gastric normal and cancer tissues. No arginase immunoreactivity was observed in normal mucosal gland, muscular and serosal tissues or benign gastric ulcers. The immunoreactivity of arginase was positive but heterogeneous in most specimens of gastric adenocarcinoma (62.2%) and was absent from gastric intestinal metaplasia, leiomyomas and leiomyosarcomas. Among the 28 neoplasms with arginase immunoreactivity, scattered immunoreactivity was also noted in adjacent dysplastic glands in 12 (42.8%) specimens. Arginase immunoreactivity was observed in all three gastric cancer cell lines. Arginase is present in the cytoplasm but not in the nucleus. These data suggest that the high arginase levels in adenocarcinoma cancer tissues originate largely from cancer cells.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Barranco SC, Townsend CM, Cacilda Casartelli, Macik BG, Burger NL, Boerwinkle WR, Courley EK (1983) Establishment and characterization of an in vitro model system for human adenocarcinoma of the stomach. Cancer Res 43:1703–1709
Cabello J, Prajoux V, Plaza M (1965) Immunodiffusion studies on human liver and erythrocytes arginases. Biochim Biophys Acta 105:583–593
Colombo JP, Konarska L (1984) Arginase. In: Bergmeyer HU, Bergmeyer J, Grassl M (eds) Esterases, glycosidases, lyases. (Methods of enzymatic analysis, vol 2) Verlag Chemie, Weinheim, pp 285–294
Harris B, Pretlow TP, Bradley EL, Whitehurst GB, Pretlow TG (1983) Arginase activity in prostatic tissue of patients with benign prostatic hyperplasia and prostatic carcinoma. Cancer Res 43:3008–3012
Hsu SM, Raine L, Fanger H (1981) A comparative study of the peroxidase antiperoxidase method and an avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies. Am J Clin Pathol 75:734–738
Huang MH, Yu CL, Han SH, Chiang BN, Wang SR (1990) Evidence that an immunosuppressive protein from murine liver is arginase. Biomed Biochim Acta 49:179–187
Japanese Research Society for Gastric Cancer (1981) The general rules for the gastric cancer study in surgery and pathology. Jpn J Surg 11:127–145
Jin LD, Meng CL, Han SH, Ding MJ, Chang TM, Chen TK, Shen KL (1987) A study on production of monoclonal antibodies using SC-M1 cell as immunogen. Med Sci 8:17–25
Kung JT, Brooks SB, Jakway JP, Leonard LL, Talmage DW (1977) Suppression of in vitro cytotoxic response by macrophages due to induced arginase. J Exp Med 146:665–672
Lauren P (1965) The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 64:31–49
Leu SY, Wang SR (1992) Clinical significance of arginase in colorectal cancer. Cancer 70:733–736
Multhaupt H, Fritz P, Schumacher K (1987) Immunohistochemical localisation of arginase in human liver using monoclonal antibodies against human liver arginase. Histochemistry 87:465–470
Porembska Z, Kedra M (1975) Early diagnosis of myocardial infarction by arginase activity determination. Clin Chim Acta 60:355–361
Schneider E, Dy M (1985) The role of arginase in the immune response. Immunol Today 6:136–140
Schumacher K, Maerker-Alzer G, Wehmer U (1974) A lymphocyte-inhibiting factor isolated from normal human liver. Nature 251:655–656
Sekiguchi M, Sakakibara K, Fujii G (1978) Establishment of cultured cell lines derived from a human gastric carcinoma. Jpn J Exp Med 48:61–68
Su HL, Huang MH, Yu CL, Han SH, Chiang BN, Wang SR (1987) Modulation of lymphocyte proliferation by murine liver extract. Asia Pac J Allergy Immunol 5:17–24
Wang SR, Chen ML, Huang MH, Lin HY, Tsai JJ, Kuo IT (1993) Plasma arginase concentration measured by an enzyme-linked immunosorbent assay (ELISA) in normal adult population. Clin Biochem 26:455–460
Watanabe H, Jass JR, Sobin LH (1990) Histological typing of oesophageal and gastric tumours, 2nd edn. (WHO International Histological Classification of Tumours) Springer, Berlin Heidelberg New York, pp 22–23
Wu CW, Chi CW, Tsay SH, Lui WY, P'eng FK, Chang KL, Huang MH, Wang SR (1987) The effects of arginase on neoplasm. I. The role of arginase in the immunosuppressive effects of extract from gastric cancer. Chin J Microbiol Immunol 20:279–289
Wu CW, Wang SR, Chang TJ, Lin EC, Chang KL, Huang MH, Lui WY, P'eng FK, Chi CW (1989) Content of glucocorticoid receptor and arginase in gastric cancer and normal gastric mucosal tissues. Cancer 64:2552–2556
Wu CW, Wang SR, Chien SL, Yeh TH, Lian SL, Shimizu N, Lui WY, P'eng FK, Chi CW (1992) Regulation of arginase production by glucocorticoid in three human gastric cancer cell lines. Life Sci 51:1355–1361
Wu CW, Chi CW, Lin EC, Lui WY, P'eng FK, Wang SR (1994) Serum arginase level in patients with gastric cancer. J Clin Gastroenterol 18:84–85
Wu CW, Chi CW, Ho CK, Chien SL, Lui WY, P'eng FK, Wang SR (1994) Effect of arginase on splenic killer cell activity in patients with gastric cancer. Dig Dis Sci 39:1107–1112
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wu, CW., Kao, HL., Lui, WY. et al. Immunohistochemical study of arginase in cancer of the stomach. Vichows Archiv A Pathol Anat 428, 325–331 (1996). https://doi.org/10.1007/BF00202199
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00202199